Brief: Lee's Pharmaceutical Says On 25 June, Unit & Panoptica Entered Binding Letter Of Intent
02/07/2020 06:41
July 2 (Reuters) - Lee's Pharmaceutical Holdings Ltd
0950.HK :
* ON 25 JUNE, UNIT & PANOPTICA, INC. ENTERED INTO BINDING
LETTER
OF INTENT
* LOI FOR EXCLUSIVE RIGHTS TO DEVELOP, MANUFACTURE &
COMMERCIALISE
PAN-90806 IN CHINA, HK, MACAU, SOUTH KOREA & OTHERS IN SE ASIA
* BOTH PARTIES PLAN TO COLLABORATE IN WORLD-WIDE DEVELOPMENT
OF
PAN-90806 IN WET AGE-RELATED MACULAR DEGENERATION
Source text for Eikon: ID:nHKS6Wrz0B
Further company coverage: 0950.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lee's Pharmaceutical Holdings
See all newsHong Kong's Lee's Pharmaceutical H1 profit jumps on higher-margin product sales
Brief: Lee's Pharmaceutical Expects H1 Net Profit Of HK$85 Million-HK$95 Million
Brief: Lee's Pharmaceutical Says Investigational New Drug Application For ADC Project ZK2401 Accepted By NMPA
Brief: Ashlins Pharmaceuticals And Lee's Pharm Announce Exclusive License And Supply Agreement Valued At Up To $31 Million
Brief: Lee's Pharmaceutical Says Entered Licensing Agreement With Ashlins Ocular Pharmaceuticals